Atrium Evolution Series — Diversified Fund AEF 9 is an Managed Funds investment product that is benchmarked against Multi-Asset Growth Investor Index and sits inside the Multi-Asset - Specialised Index. Think of a benchmark as a standard where investment performance can be measured. Typically, market indices like the ASX200 and market-segment stock indexes are used for this purpose. The Atrium Evolution Series — Diversified Fund AEF 9 has Assets Under Management of 310.67 M with a management fee of 2.11%, a performance fee of 0.00% and a buy/sell spread fee of 0.3%.
The commencement of the new fiscal year witnessed the continuation of a robust upward trend in global equity markets. During this period, the Fund registered a favourable performance, largely attributed to the contributions from equities.
Among equities, both domestic and international stocks yielded substantial gains throughout the month. Standout performers included Fairlight Global Small and Midcap Fund, Hyperion Global Growth Companies Fund, and Antipodes Global Fund – Long Only. The latter effectively capitalized on a vigorous recovery in emerging markets and cyclical stocks. On the other hand, certain areas of our listed infrastructure exposure struggled to keep pace, as investor sentiment shifted towards growth and cyclical stocks while steering away from defensive assets.
The performance of our liquid alternative investments exhibited a more varied pattern. The Crown Diversified Macro Segregated Portfolio achieved positive returns, while our risk premia and currency strategies experienced a downturn over the same period. Our recent venture into insurance bonds has proven to be fruitful thus far.
Product Snapshot
Performance Review
Product Overview
Peer Comparison
Product Details